Needham analyst David Saxon reiterated a Buy rating on Irhythm Technologies (IRTC – Research Report) today and set a price target of $179.00. The company's shares closed last Thursday at $115.07. According to TipRanks.com, Saxon is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of -9.4% and a 27.9% success rate. Saxon covers the Healthcare sector, focusing on stocks such as Alphatec Holdings, Staar Surgical, and Globus Medical. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Irhythm Technologies with a $154.14 average price target, implying a 39.4% upside from current levels.
https://www.tipranks.com/news/blurbs/needham-remains-a-buy-on-irhythm-technologies-irtc?utm_source=advfn.com&utm_medium=referral
iRhythm Technologies (NASDAQ:IRTC)
Historical Stock Chart
From Feb 2023 to Mar 2023 Click Here for more iRhythm Technologies Charts.
iRhythm Technologies (NASDAQ:IRTC)
Historical Stock Chart
From Mar 2022 to Mar 2023 Click Here for more iRhythm Technologies Charts.